Clincosm LogoSign in Get a demo

ovarian clear cell carcinoma

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Clear Cell Carcinoma Trial in Houston (Dostarlimab, LB-100)

Not yet recruiting
  • Ovarian Clear Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 26, 2023

Ovarian Clear Cell Carcinoma Trial (Zimberelimab, Metformin Hydrochloride)

Not yet recruiting
  • Ovarian Clear Cell Carcinoma
  • (no location specified)
Feb 25, 2023

Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer, Gastric Cancer Trial in New Haven (APG-5918)

Recruiting
  • Nasopharyngeal Carcinoma
  • +8 more
  • Springdale, Arkansas
    Highlands Oncology
Nov 11, 2022

Ovarian Clear Cell Carcinoma Trial (Camrelizumab)

Not yet recruiting
  • Ovarian Clear Cell Carcinoma
  • (no location specified)
Oct 29, 2022

Ovarian Clear Cell Carcinoma, Gynecologic Cancer Trial in Boston (Lenvatinib, Pembrolizumab)

Recruiting
  • Ovarian Clear Cell Carcinoma
  • Gynecologic Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Oct 13, 2022

Asian Multicenter Prospective Study of ctDNA Sequencing

Recruiting
  • Cervical Cancer
  • +5 more
  • NGS analysis of ctDNA
  • Tokyo, Japan
  • +18 more
Sep 28, 2022

Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer Trial in Orlando, Albuquerque

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • olvimulogene nanivacirepvec
  • +3 more
  • Orlando, Florida
    AdventHealth Cancer Institute
Sep 1, 2022

Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

Not yet recruiting
  • Advanced Solid Tumor
  • +18 more
  • (no location specified)
Aug 10, 2022

Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

Completed
  • Small Cell Lung Cancer
  • +7 more
  • Scottsdale, Arizona
  • +4 more
Jul 20, 2022

Ovarian Clear Cell Carcinoma Trial in Wuhan (Sintilimab, Bevacizumab Biosimilar IBI305)

Recruiting
  • Ovarian Clear Cell Carcinoma
  • Wuhan, Hubei, China
    Tongji Hospital of Tongji Medical College, Huazhong University o
Apr 18, 2022

Renal Cell Carcinoma (RCC), Clear-cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Trial in United States (CDX-014)

Terminated
  • Renal Cell Carcinoma (RCC)
  • +5 more
  • Scottsdale, Arizona
  • +4 more
Jun 2, 2020

Ovarian Clear Cell Carcinoma Trial in Canada (ENMD-2076)

Completed
Has Results
  • Ovarian Clear Cell Carcinoma
  • Calgary, Alberta, Canada
  • +5 more
Dec 12, 2019

Ovarian Clear Cell Carcinoma Trial in Singapore (durvalumab, standard chemo)

Unknown status
  • Ovarian Clear Cell Carcinoma
  • Singapore, Singapore
  • +1 more
May 16, 2018

Ovarian Clear Cell Carcinoma, Endometrial Clear Cell Carcinoma Trial in United Kingdom (Nintedanib, Paclitaxel, Pegylated

Unknown status
  • Ovarian Clear Cell Carcinoma
  • Endometrial Clear Cell Carcinoma
  • Glasgow, Lanarkshire, United Kingdom
  • +16 more
Aug 10, 2016